Delivery Order SPE2DB20D1051-SPE2DB25FD9CM
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,225.77 to supply Mounjaro (tirzepatide) 5 mg/0.5 mL pens, with a completion date of August 4, 2025. This competitively awarded, firm fixed-price contract does not include a set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran...
- The Defense Logistics Agency awarded a $1,187.75 delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Mounjaro (tirzepatide) 15 mg/0.5 mL pens. This is a firm fixed price, competitively awarded contract with a completion date of August 11, 2025, and represents a child delivery order under AmerisourceBergen's larger prime indefinite delivery contract (IDC) with DLA Troop Support Medical. The work will be performed at the contractor's corporate office in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $12,759.36 to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Mounjaro (tirzepatide) 7.5 mg/0.5 mL pen injectors. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by July 28, 2025. The order will be fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,800.96 to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Mounjaro (tirzepatide) 7.5 mg/0.5 mL pens. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of July 29, 2025, to be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement,...
- The Defense Logistics Agency awarded a $3,537.17 firm fixed price delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Mounjaro (tirzepatide) 5 mg/0.5 mL pens in 0.5 mL unit doses. The contract, which is a non-set-aside competitive award with an ultimate completion date of July 25, 2025, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,904.63 to AmerisourceBergen Drug Corp for Mounjaro (tirzepatide) 15 mg/0.5 ml pens on July 22, 2025, with completion scheduled for July 23, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Mounjaro is a GLP-1 receptor agonist used for diabetes management, representing part of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Mounjaro (tirzepatide) 10 mg/0.5 mL pen injectors at a ceiling value of $3,281.64. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of July 24, 2025, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a small-value pharmaceutical procurement supporting federal...
- The Defense Logistics Agency awarded a $1,632.54 delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Mounjaro (tirzepatide) 7.5 mg/0.5 mL pens with a completion date of July 22, 2025. This firm fixed price delivery order is unclassified with no set-aside provisions and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Mounjaro is a GLP-1 receptor agonist indicated for diabetes management, representing part of the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Mounjaro (tirzepatide) 7.5 mg/0.5 mL pen injections, with a contract ceiling value of $6,235.50. This competitively awarded, firm fixed-price delivery order was issued on August 4, 2025, with an ultimate completion date of August 5, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation,...
- The Defense Logistics Agency awarded a $6,530.16 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 mL pens on July 30, 2025, with an ultimate completion date of July 31, 2025. This non-competitive delivery order represents a single pharmaceutical product delivery executed under the company's existing contract vehicle with DLA. Mounjaro is a tirzepatide-based diabetes medication, consistent with AmerisourceBergen's extensive portfolio of...
- SPE2DB20D1051Indefinite Delivery Contract
- SPE2DB20D1051-SPE2DB25FD9CMDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $6,560.81 to AmerisourceBergen Drug Corp for Mounjaro (tirzepatide) 5 mg/0.5 mL pens on August 19, 2025, with completion expected by August 20, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award for pharmaceutical supply to support federal medical procurement needs. The product will be performed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This comprehensive prime vendor contract serves as a global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications, vaccines, medical devices, and healthcare commodities to support military healthcare programs and other federal healthcare systems, including the Defense Health Agency and U.S. Coast Guard. The contract reflects DLA's strategy of maintaining multiple pharmaceutical prime vendors to ensure reliable medical supply chain support across global military operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.6k | 8/19/25 |